We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Venture Life Group Plc | LSE:VLG | London | Ordinary Share | GB00BFPM8908 | ORD 0.3P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 38.50 | 38.00 | 39.00 | 38.50 | 38.50 | 38.50 | 10,927 | 08:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Misc Retail Stores, Nec | 43.98M | 520k | 0.0041 | 93.90 | 48.45M |
TIDMVLG
Venture Life Group PLC
20 December 2016
20 December 2016
Venture Life Group plc
("Venture Life", the "Company" or the "Group")
Investor evening
Venture Life (AIM: VLG), the international consumer self-care group focused on developing, manufacturing and commercialising products for the ageing population, announces that it will be hosting a presentation for investors on the afternoon of Thursday 26 January 2017.
Jerry Randall, CEO will provide an overview of the Company and where it is currently positioned. The afternoon will also feature presentations by:
-- Mr Vincent Poujardieu, Vice President of Rasio Group plc and General Manager of the Benecol Division. Vincent will be speaking about Benecol and the benefits the brand offers as a functional food and a food supplement.
-- Mr Gianluca Braguti, founder of Biokosmes and Development and Manufacturing Director at Venture Life. Gianluca will be speaking about the new products developed at Biokosmes, including new Benecol products, to be launched in 2017 by Venture Life.
-- Dr Mervyn Druian, Aesthetic Dentist. Mervyn originally brought the UltraDEX product to the UK more than 20 years ago. He has successfully used UltraDEX long term in his clinic in Primrose Hill, and will be speaking about the benefits of UltraDEX for his patients and the advantages it offers over the competition.
-- Mr Tim Scott, UK Sales Director, Venture Life. Tim has recently joined Venture Life and has extensive experience in the UK retail pharmacy space. Tim will talk about the UK market trends in both the pharmacy and grocery sector and also about the commercial opportunity for UltraDEX in the UK.
The presentation will be held at the offices of Panmure Gordon, One New Change, London EC4M 9AF. The event will begin at 3pm, and after brief presentations, drinks and canapes will be served to allow guests to talk further with the speakers.
Space is limited so please register your interest, please contact venturelife@walbrookpr.com or call 020 7933 8780.
No new material or trading information will be provided.
For further information please contact:
Hot Features
Premium
Venture Life Group PLC +44 (0) 1344 742870
Jerry Randall, Chief Executive
Officer
Panmure Gordon (UK) Limited (Nominated +44 (0) 20 7886
Adviser and Joint Broker) 2500
Freddy Crossley/Peter Steel/Duncan
Monteith (Corporate Finance)
Tom Salvesen (Corporate Broking)
Turner Pope Investments (TPI) Ltd +44 (0) 20 3621
(Joint Broker) 4120
James Pope/Ben Turner
Walbrook PR venturelife@walbrookpr.com
or +44 (0) 20 7933 8780
Paul McManus/Anna Dunphy +44 (0) 7980 541 893 / +44
(0) 7876 741 001
This information is provided by RNS
The company news service from the London Stock Exchange
END
NRALLFERFSLALIR
(END) Dow Jones Newswires
December 20, 2016 02:00 ET (07:00 GMT)
1 Year Venture Life Chart |
1 Month Venture Life Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
